Cara F Smith, Cassandra M Modahl, David Ceja-Galindo, Keira Y Larson, Sean P Maroney, Lilyrose Bahrabadi, Nicklaus P Brandehoff, Blair W Perry, Maxwell C McCabe, Daniel Petras, Bruno Lomonte, Juan J Calvete, Todd A Castoe, Stephen P Mackessy, Kirk C Hansen, Anthony J Saviola
New treatments that circumvent the pitfalls of traditional antivenom therapies are critical to address the problem of snakebite globally. Numerous snake venom toxin inhibitors have shown promising cross-species neutralization of medically significant venom toxins in vivo and in vitro. The development of high-throughput approaches for the screening of such inhibitors could accelerate their identification, testing, and implementation, and thus holds exciting potential for improving the treatments and outcomes of snakebite envenomation worldwide...
April 26, 2024: Molecular & Cellular Proteomics: MCP